Member Info for Laura2022

I can sense all you long termers are angry and bitter

But buying a pre revenue/small revenue cash guzzling company at £20/30/40mln+ valuations is poor due diligence

See my top ups last week :)

I feel for those at 99.9% loss

Enjoy your Sunday and your green bin

Your ladt 2yrs of posts says everything

Not my fault you cry babies were buying at 20p/30p/40p

In fact

Not really posted since May 2024

Then pop up

Strange

Nice one

You also like PXEN which has horrific balanc sheet and SOUC which went bust

Nice one

You and Dug should be friends;)

My tops up were 1.10 and 1.15p ...i can see why you're bitter

I can see why you're angry

I've bought at a fraction that you did

Like i said to Kong

Why were you buying at 25p-50p valuation ???

DugWalker

Posted in: OBD

Posts: 577

Price: 28.00

No Opinion

RE: Going17 Jan 2024 08:23

Managed to grab a top up.

DugWalker

Posted in: OBD

Posts: 577

Price: 31.00

No Opinion

RE: Drop17 Jan 2024 08:19

Can't.get an online quote to buy.

Hence why I added JV

Please read ..it would help you .

Xx

69 posts Dug on OBD

And only 10 on others

Get a hobby

Bets on when Porky replies as he'll be reading this a see know he can't stay away

I'm going for 0300am to 05.00am

Yes

It's my view that ENET and OBD for very similar reasons will be biggest movers next week

All the round sells are them

30mln cleared last week

My apologies

You're right

Does that explain the vitriol?

Somehow ..in a warped form of logic ..he blames VAL for him selling VAL and ploughing it into DDDD and NCYT?

Only reason that may explain such vitriol towards VAL out of all the other AIM companies that have suffered the same 4 problems I mentioned this morning that affect 100s of AIM companies

Incredible PP

That is ...all laid bare...the mind of a sociopath

Thankyou

Including some for after 4.30pm and covers the missing Friday trades from 2pm onwards

https://www.londonstockexchange.com/stock/OBD/oxford-biodynamics-plc/company-page

They don't need?

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that Prevail Partners, LLC ("Prevail Partners"), an investment fund, has agreed to invest a total of $350,000 (approximately £269,000) in the Company through a subscription for ordinary shares in the Company at a price of US$0.075 per share (approximately 5.6p). This follows a similar investment in the Company by Prevail Partners annou

Where have they said this please ?